Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A myelodysplastic syndrome characterized by dysplasia seen in at least 10% of the early cells of 1 cell type (either red blood cells, white blood cells, or megakaryocytes) in the bone marrow.
Biomarker and diagnostic research for myelodysplastic syndrome with single lineage dysplasia has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
3 clinical trials registered. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
19 publications have been identified in PubMed for myelodysplastic syndrome with single lineage dysplasia. Research spans Case Report / Case Series (42%), Basic Science / Preclinical (21%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 1:38 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
42%
Laboratory research | 4 | 21% |
Testing and diagnosis research | 3 | 16% |
Disease patterns and progression | 3 | 16% |
Research summaries | 1 | 5% |
Bai L (2026). [PMID: 41529258](https://pubmed.ncbi.nlm.nih.gov/41529258/). *JMIR research protocols*. [Case Report / Case Series]
Zhang YX (2026). [PMID: 42227433](https://pubmed.ncbi.nlm.nih.gov/42227433/). *Zhongguo Shi Yan Xue Ye Xue Za Zhi*. [Diagnostic / Biomarker]
Devathasan J (2026). [PMID: 41601277](https://pubmed.ncbi.nlm.nih.gov/41601277/). *Nephrology (Carlton, Vic.)*. [Case Report / Case Series]
Bhat P (2025). [PMID: 40972808](https://pubmed.ncbi.nlm.nih.gov/40972808/). *Experimental hematology*. [Epidemiology / Natural History]
Shim KG (2025). [PMID: 40746769](https://pubmed.ncbi.nlm.nih.gov/40746769/). *Clinical case reports*. [Case Report / Case Series]
Sae-Wong J (2025). [PMID: 40400103](https://pubmed.ncbi.nlm.nih.gov/40400103/). *Paediatrics and international child health*. [Case Report / Case Series]
Kaur G (2025). [PMID: 38391342](https://pubmed.ncbi.nlm.nih.gov/38391342/). *Indian journal of pathology & microbiology*. [Case Report / Case Series]
Bell CE (2025). [PMID: 41419236](https://pubmed.ncbi.nlm.nih.gov/41419236/). *BMJ case reports*. [Case Report / Case Series]
Liang J (2025). [PMID: 40675789](https://pubmed.ncbi.nlm.nih.gov/40675789/). *ESC heart failure*. [Epidemiology / Natural History]
Sirenko M (2024). [PMID: 38687605](https://pubmed.ncbi.nlm.nih.gov/38687605/). *Blood*. [Basic Science / Preclinical]